Report Highlights
The global market for clinical nutrition is estimated to grow from $59.6 billion in 2020 to $75.4 billion by 2025, at a compound annual growth rate (CAGR) of 4.8% during the forecast period of 2020-2025.
Report Includes
- 28 data tables and 55 additional tables
- An updated review of the global market for clinical nutrition within the industry
- Analyses of the global market trends, with data from 2018-2020, and projections of compound annual growth rates (CAGRs) through 2025
- Highlights of the key market regulations, new advances in clinical nutrition and nutritional sciences, and increasing demand for specific nutritional products; and their impact on the stakeholders in this market
- Estimation of current market size and potential growth forecast for clinical nutrition market, and corresponding market share analysis by nutrition type, end user, application area, and geography
- Analysis of market opportunities with a holistic study of Porter’s Analysis and PEST Analysis for relevant geographic regions in the clinical nutrition industry
- Competitive Landscape featuring major companies in the clinical nutrition market, their financial information, company share analysis and key development strategies
- Review of the U.S. patents issued for innovations in clinical nutrition products
- Profile description of the market leading players, including Abbott, B. Braun Melsungen AG, Baxter, Danone, DSM, Mead Johnson Nutrition Co. (MJN), Nestlé and Fresenius Kabi
Report Scope
Clinical nutrition is nutrition for patients in a healthcare setting. It is the practice of assessing whether a person is consuming an adequate amount of nutrients. This report analyzes market trends for clinical nutrition with data from 2018-2019, estimates from 2020, projections of compound annual growth rates (CAGR) through 2025 (forecast period 2020-2025) and regional markets for clinical nutrition.
The market has been segmented by type, application, end user and geography. By type, the market is segmented into enteral nutrition, parenteral nutrition and infant nutrition. The infant nutrition segment covers milk-based, organic, soy-based, prebiotics, probiotics and follow-up products. The enteral nutrition segment covers standard nutrition and disease-specific nutritional support. The parenteral nutrition segment in this report includes carbohydrates, lipids, trace elements, amino acids, vitamins and minerals. Products include, but are not limited to, the segments considered in this report. The applications of clinical nutrition considered in this report include therapeutic applications and healthcare settings. In therapeutic applications, the report covers oncology, gastroenterology, nephrology, neurology, diabetes, immunology, critical care and other diseases. The healthcare settings segment includes acute care hospitals, nursing homes, homecare settings and inpatient rehabilitation facilities. This report also includes a detailed background of medical nutrition therapy: oral nutrition supplements (dietary supplements, functional and fortified foods and food intolerance products) and clinical nutrition routes, enteral and parenteral. Market sizing was done for infant, enteral, parenteral, adult and elder nutrition. A regional market analysis for clinical nutrition is also covered in this report.
The research uncovers many paradigm shifts in the studied market, in terms of regional competitive advantage, competitive landscape among key players and market dynamics. A holistic study of the market has been carried out, incorporating various factors, from country-specific demographic conditions and business cycles to market specific microeconomic influences needed to analyze the future trends of this market. The report provides a comprehensive review of market drivers, restraints, opportunities and available patents. Key vendor analysis, new products, developments and financials are also provided, to enable easy decision making.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Liver Disease Treatments: The Global Market (PHM057D)
- Global Fuel Cell Stack Market (FCB070A)
- 2024 Sustainable Energy Research Review (EGY202A)
- Medical Aesthetic Devices: Technologies and Global Markets (HLC056E)
- Renewable Energy: Technologies and Global Markets (EGY049F)
Report Highlights
The global clinical nutrition market should reach $60.8 billion by 2022 from $48.2 billion in 2017 at a compound annual growth rate (CAGR) of 4.8% for the period 2017-2022.
Report Includes
- 50 data tables and 46 additional tables
- An overview of global markets for clinical nutrition within the industry
- Analyses of global market trends. with data from 2016 to 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Quantification and segmentation of the clinical nutrition market by regions, end users, and nutrition types
- Examination of market dynamics, along with growth driving factors, opportunities, restraints etc.
- Identification of shifts in the market, in terms of regional competitive advantage, and the competitive landscape among key players
- Comprehensive company profiles of major players in the market, including Atrium Innovations, Abbott Nutrition, Baxter International, DuPont Nutrition & Health, Glanbia Plc, Lonza Group Ltd., Nestlé SA, and Pfizer, Inc.
Related Reports
The Global Market for Carotenoids
The global market for carotenoids is estimated to increase from $2.1 billion in 2024 to reach $2.9 billion by 2029, at a compound annual growth rate (CAGR) of 6.7% from 2024 through 2029.
Intravenous (IV) Therapy and Vein Access: Global Markets
The global market for IV therapy and venous access devices is expected to grow from $57.0 billion in 2024 and is projected to reach $74.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2024 to 2029.
Probiotics in Food, Beverages, Dietary Supplements and Animal Feed
The global market for probiotics is expected to grow from $69.8 billion in 2024 and is projected to reach $102.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.9% during the forecast period of 2024 to 2029.
Nutraceuticals: Global Markets
The global market for nutraceuticals is expected to grow from $418.2 billion in 2024 and is projected to reach $571.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2024 to 2029.
Recent Reports
Liver Disease Treatments: The Global Market
The global market for liver disease treatments is estimated to increase from $46.0 billion in 2024 to reach $69.1 billion by 2030, at a compound annual growth rate (CAGR) of 7.1% from 2025 through 2030.
Cancer Immunotherapy: Technologies and Global Markets
The global cancer immunotherapy market is expected to grow from $144.2 billion in 2024 and is projected to reach $247.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.4% during the forecast period of 2024 to 2029.
Nanotechnology in Cancer Treatment: Technologies and Global Markets
The report provides an analysis of the global market for nanotechnology in cancer treatment. Using 2023 as the base year, the report provides estimated market data for 2024 through 2029. The market in this report is segmented into product type, cancer type, and region. The report concludes with profiles of the major players in the market.
Radiopharmaceuticals: Technologies and Global Markets
The global radiopharmaceuticals market is expected to grow from $10.3 billion in 2024 and is projected to reach $21.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 16.4% during the forecast period of 2024 to 2029.
Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions
The global market for cancer therapeutics emphasizing recurrent and metastatic divisions is expected to grow from $116.1 billion in 2024 to reach $168.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2029.
Top Trending Reports
Global Diabetic Care Devices Market
The global market for diabetes monitoring devices is expected to grow from $16.6 billion in 2024 to $26.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.1% from 2024 through 2029.
2024 Semiconductor Manufacturing Research Review
This 2024 Research Review of the Semiconductor Manufacturing provides a sampling of the type of quantitative market information, analysis, and guidance that BCC Research has been developing since its inception in 1971 to help its customers make informed business decisions.
Carbon Capture, Utilization & Storage Technologies
The global market for carbon capture, utilization and storage (CCUS) technologies is expected to grow from $3.4 billion in 2024 and is projected to reach $9.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.1% during the forecast period of 2024 to 2029.
Generative AI: Global Markets
The global market for generative AI was valued at $15.4 billion in 2023. It is projected to grow from $20.8 billion in 2024 to $94.4 billion by 2029, at a compound annual growth rate (CAGR) of 35.3% from 2024 through 2029.
2024 Medical Devices Research Review
The medical device industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years These devices treat and diagnose a multitude of patient conditions and work much better than drugs.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More